Brontictuzumab Biosimilar – Anti-NOTCH1 mAb – Research Grade

Reference:
Size

,

Isotype

IgG2-lambda

Brand

Product type

Clonality

Expression system

Applications

,

Product nameBrontictuzumab Biosimilar - Anti-NOTCH1 mAb - Research Grade
SourceCAS 1447814-75-6
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsBrontictuzumab,OMP-52M51,NOTCH1,anti-NOTCH1
ReferencePX-TA1347
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-lambda
ClonalityMonoclonal Antibody

Description of Brontictuzumab Biosimilar - Anti-NOTCH1 mAb - Research Grade

General information on Anti-NOTCH1[Homo sapiens] (Brontictuzumab) Monoclonal Antibody

Brontictuzumab has been investigated in the treatment of adenoid cystic carcinoma, relapsed or refractory solid tumors, and lymphoid malignancies.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Brontictuzumab Biosimilar – Anti-NOTCH1 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products